Pharmacokinetic evaluation of [18F]PR04.MZ for PET/CT imaging and quantification of dopamine transporters in the human brain.
Vasko KramerCarlos JuriPatrick J RissRossana PruzzoCristian Soza-RiedJonathan FloresAna HurtadoFrank RöschPedro Chana-CuevasHoracio AmaralPublished in: European journal of nuclear medicine and molecular imaging (2019)
[18F]PR04.MZ is a PET tracer with very high affinity, selectivity, and specific uptake in striatum and midbrain. 2TCM and SRTM provide good fits, high and stable Vts or BPnds, and good test-retest reliability for precise quantification of DAT in human subjects.